SCHEMBL2326396

SCHEMBL2326396

Cc1ccc2ccc(S(=O)(=O)C(F)(F)F)cc2c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.50
CYP1A2 P05177 2/20 0.50
POLB P06746 1/20 0.49
ALDH1A1 P00352 4/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
TSHR P16473 2/20 0.48
USP2 O75604 1/20 0.48
HPGD P15428 1/20 0.48
MAPK1 P28482 1/20 0.48
HSD17B10 Q99714 1/20 0.48
EPAS1 Q99814 3/20 0.46
LMNA P02545 2/20 0.44
HTT P42858 1/20 0.44
ESPL1 Q14674 1/20 0.44
PTPN1 P18031 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KIF11 P52732 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7197925 0.89 ALDH1A1 (0.59) POLBALDH1A1SMN1; SMN2MAPK1EPAS1
SCHEMBL20656774 0.83 ALDH1A1 (0.57) POLBALDH1A1SMN1; SMN2MAPK1EPAS1
SCHEMBL23520947 0.79 LMNA (0.57) POLBALDH1A1SMN1; SMN2TSHRLMNA
SCHEMBL1098295 0.78 GAA (0.54) POLBALDH1A1SMN1; SMN2MAPK1EPAS1
SCHEMBL2329828 0.78 CYP1A2 (0.46) CYP2A6CYP1A2POLBALDH1A1SMN1; SMN2
SCHEMBL2330600 0.78 MEN1 (0.50) CYP2A6CYP1A2POLBALDH1A1SMN1; SMN2
SCHEMBL12267589 0.77 CYP2A6 (0.58) CYP2A6CYP1A2ALDH1A1SMN1; SMN2TSHR
SCHEMBL5989844 0.76 ALDH1A1 (0.50) POLBALDH1A1SMN1; SMN2MAPK1EPAS1
SCHEMBL2327407 0.76 CYP2A6 (0.56) CYP2A6CYP1A2ALDH1A1SMN1; SMN2TSHR
SCHEMBL889908 0.76 SNCA (0.62) CYP2A6CYP1A2ALDH1A1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0853618-B1 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL -AZAHETEROCYCLYLAMIDE COMPOUNDS AVENTIS PHARMA INC (US) 2011-08-17 EP disclosed
EP-0853618-A4 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHONE POULENC RORER PHARMA (US) 2000-03-15 EP disclosed
US-5958918-A Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N- (aminominomethyl)phenylalkyl!-azaheterocyclylamide compounds RHONE-POULENC RORER PHARMACEUTICALS INC. 1999-09-28 US disclosed
EP-0853618-A1 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1998-07-22 EP disclosed
WO-1996040679-A1 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N-[(AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHÔNE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-12-19 WO disclosed